Umile Giuseppe Longo has been the Deputy Scientific Director at Campus Bio-Medico University Polyclinic Foundation since 2022, and a Full Professor of Locomotor System Diseases at Campus Bio-Medico University of Rome since 2020. He was a scientific co-director of the Higher Education Course in Hip Pathologies and Surgery at Campus Bio-Medico University of Rome in 2022 and the Head of the Traumatology and Sports Medicine Unit at Campus Bio-Medico University Polyclinic Foundation in 2021. He obtained a Specialization Diploma in Orthopedics and Traumatology at Campus Bio-Medico University of Rome in 2009 and a PhD in Orthopedics and Traumatology at Utrecht University (Holland) in 2012. The main areas of clinical activity include primary and revision prosthetic surgery (shoulder, hip, knee, and ankle); arthroscopic surgery (shoulder, knee, and ankle); sports traumatology (complex knee ligament injuries, meniscal injuries, rotator cuff injuries, and treatment of shoulder instability); and cellular therapies with a vascular fraction derived from adipose tissue, mesenchymal cells derived from the iliac crest, and growth factors.
Umile Giuseppe Longo has been the Deputy Scientific Director at Campus Bio-Medico University Polyclinic Foundation since 2022, and a Full Professor of Locomotor System Diseases at Campus Bio-Medico University of Rome since 2020. He was a scientific co-director of the Higher Education Course in Hip Pathologies and Surgery at Campus Bio-Medico University of Rome in 2022 and the Head of the Traumatology and Sports Medicine Unit at Campus Bio-Medico University Polyclinic Foundation in 2021. He obtained a Specialization Diploma in Orthopedics and Traumatology at Campus Bio-Medico University of Rome in 2009 and a PhD in Orthopedics and Traumatology at Utrecht University (Holland) in 2012. The main areas of clinical activity include primary and revision prosthetic surgery (shoulder, hip, knee, and ankle); arthroscopic surgery (shoulder, knee, and ankle); sports traumatology (complex knee ligament injuries, meniscal injuries, rotator cuff injuries, and treatment of shoulder instability); and cellular therapies with a vascular fraction derived from adipose tissue, mesenchymal cells derived from the iliac crest, and growth factors.